Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Dexamethasone
Ozurdex
Routinely available
SMC (652/10)
29/03/2023
Indication
For the treatment of adult patients with macular oedema following either branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO).
Therapeutic Area
Eye
Status Description
Routinely available
Formulation
700microgram intravitreal implant
Comments
-
Link to Advice
Advice Published
11/06/2012
SMC Submission Type
Resubmission
SMC Status
Restricted